RIVELIN Trademark

Trademark Overview

On Friday, September 14, 2018, a trademark application was filed for RIVELIN with the United States Patent and Trademark Office. The USPTO has given the RIVELIN trademark a serial number of 79250499. The federal status of this trademark filing is REGISTERED as of Tuesday, December 24, 2019. This trademark is owned by Afyx Therapeutics A/S. The RIVELIN trademark is filed in the Pharmaceutical Products category with the following description:

Medical and pharmaceutical preparations and articles, namely, mucous membrane and skin adhesive patches with a drug substance for coverage of lesions and efficient and uniform drug delivery for treating skin disorders and mucosal diseases; adhesive patches with a drug substance, namely, transdermal patches for treating skin disorders and mucosal diseases; medical patches with a drug substance, namely, transdermal patches for treating skin disorders and mucosal diseases; medical wound dressing; medical bandages for dressings; transdermal and transmucosal patches for medical treatment for use in the treatment of skin disorders and mucosal diseases
rivelin

General Information

Serial Number79250499
Word MarkRIVELIN
Filing DateFriday, September 14, 2018
Status700 - REGISTERED
Status DateTuesday, December 24, 2019
Registration Number5940693
Registration DateTuesday, December 24, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2019

Trademark Statements

Goods and ServicesMedical and pharmaceutical preparations and articles, namely, mucous membrane and skin adhesive patches with a drug substance for coverage of lesions and efficient and uniform drug delivery for treating skin disorders and mucosal diseases; adhesive patches with a drug substance, namely, transdermal patches for treating skin disorders and mucosal diseases; medical patches with a drug substance, namely, transdermal patches for treating skin disorders and mucosal diseases; medical wound dressing; medical bandages for dressings; transdermal and transmucosal patches for medical treatment for use in the treatment of skin disorders and mucosal diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 1, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAfyx Therapeutics A/S
Party Type30 - Original Registrant
Legal Entity Type84 - NOT AVAILABLE
AddressDK
Party NameAfyx Therapeutics A/S
Party Type20 - Owner at Publication
Legal Entity Type84 - NOT AVAILABLE
AddressDK
Party NameAfyx Therapeutics A/S
Party Type10 - Original Applicant
Legal Entity Type84 - NOT AVAILABLE
AddressDK

Trademark Events

Event DateEvent Description
Friday, May 1, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 9, 2020FINAL DISPOSITION NOTICE SENT TO IB
Thursday, April 9, 2020FINAL DISPOSITION PROCESSED
Tuesday, March 24, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 24, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 16, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 16, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Saturday, October 5, 2019NOTIFICATION PROCESSED BY IB
Wednesday, September 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 5, 2019ASSIGNED TO LIE
Wednesday, September 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 4, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, September 4, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 4, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, September 4, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, August 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 1, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, March 9, 2019REFUSAL PROCESSED BY IB
Thursday, February 21, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 21, 2019REFUSAL PROCESSED BY MPU
Wednesday, February 13, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 12, 2019NON-FINAL ACTION WRITTEN
Tuesday, February 5, 2019APPLICATION FILING RECEIPT MAILED
Friday, February 1, 2019ASSIGNED TO EXAMINER
Friday, February 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 31, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

rivelin patches skin medical disorders diseases drug mucosal transdermal treating namely